Table 2.
Comparison of the changes in hemoglobin levels among the treatment groups.
| Hb (g/dL) | Total population | Unilateral TKA | Bilateral TKA | ||||||
|---|---|---|---|---|---|---|---|---|---|
| MPH | TXA | p value | MPH | TXA | p value | MPH | TXA | p value | |
| Preop-POD3 | 5.0 | 3.3 | < 0.001 | 4.3 | 3.1 | < 0.001 | 4.3 | 4.1 | 0.76 |
| Preop-PO1W | 3.6 | 2.9 | 0.006 | 3.7 | 2.7 | 0.001 | 3.5 | 3.7 | 0.70 |
| Preop-PO2W | 3.2 | 2.3 | 0.10 | 3.1 | 2.7 | 0.19 | 3.6 | 4.4 | 0.43 |
| Preop-PO4W | 1.4 | 1.2 | 0.35 | 1.3 | 0.8 | 0.06 | 1.8 | 1.6 | 0.67 |
Hb hemoglobin, TKA total knee arthroplasty, MPH microporous polysaccharide hemosphere, TXA tranexamic acid, POD postoperative day, PO postoperative, W week.